QT
PVLA

Quantbot Technologies’s Palvella Therapeutics PVLA Stock Holding History

Quantbot Technologies’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70.6K Buy
+462
New +$56.1K ﹤0.01% 1552

Other funds holding PVLA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Quantbot Technologies's PVLA Position: Q2 2026 in Review

Quantbot Technologies opened a new position in Palvella Therapeutics (PVLA) in Q2 2026: 462 shares worth $70.6K. The stake represents ﹤0.01% of the portfolio and ranks #1552 among its holdings.

197 funds tracked by Wall St. Rank hold PVLA as of Q2 2026.

  • Quantbot Technologies held 462 shares of Palvella Therapeutics worth $70.6K as of Q2 2026.
  • Palvella Therapeutics was a new Quantbot Technologies position in Q2 2026.
  • Palvella Therapeutics made up ﹤0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1552 holding.
  • 197 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.